Theralase Technologies Inc (TLTFF)

[BIGKAHUNA57]

Very good news!

UHN and Dr. Lothar Lilge, PhD, Senior Scientist at UHN wouldn't continue to partner with TLT without supportive evidence that there's a basis from which to continue NMIB and expand into multiple cancer applications. These incremental steps make sense to broaden the scope after the ITA and phase 1b trials.

And I do think that once ITA is approved there will be an increase in pps. My crystal ball is not clear as to how far. I'm hoping for $.50-$.60 based on the cancer division alone. And another $.20-$30 for the TLT-2000 sales.

Regards,
BK